<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17181">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883218</url>
  </required_header>
  <id_info>
    <org_study_id>2014ZDSYLL087.0</org_study_id>
    <nct_id>NCT02883218</nct_id>
  </id_info>
  <brief_title>Observational Study to Understand the Impact of Community-acquired Sepsis Patients'Immunosuppression in Early Stage to Prognosis</brief_title>
  <acronym>CSIP</acronym>
  <official_title>Observational Study to Understand the Impact of Community-acquired Sepsis Patients'Immunosuppression in Early Stage to Prognosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jianfeng Xie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southeast University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to understand the impact community-acquired sepsis
      patients'immunosuppression in early stage to prognosis,including mortality and chance of
      secondary infection.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>28-day</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Sepsis</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients admitted to the ICU with diagnosis of sepsis and complicatied with organ
        dysfunction no longer than 48 h.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 18 years of age and no more than 90 years of age

          -  sepsis was defined according to consensus criteria

          -  diagnosis of sepsis and complicatied with organ dysfunction no longer than 48 h

          -  provided written informed consent.

        Exclusion Criteria:

          -  diagnosis of hematological,immunological disease or cancer

          -  treatment with chemotherapy agents or corticosteroids within 6 months prior to or
             during the hospitalization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jianfeng Xie, Dr</last_name>
    <phone>+862583262550</phone>
    <email>xueming0304@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haibo Qiu, Dr</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongda Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haibo Qiu, Prof</last_name>
      <phone>+862583262550</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 31, 2016</lastchanged_date>
  <firstreceived_date>August 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Southeast University, China</investigator_affiliation>
    <investigator_full_name>Jianfeng Xie</investigator_full_name>
    <investigator_title>doctor in Intensive Care Unit</investigator_title>
  </responsible_party>
  <keyword>immunosuppression</keyword>
  <keyword>community-acquired sepsis</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
